EMCDDA. New drugs in Europe, 2013, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2014. 311 kB.
Nakajima, J; Takahashi, M; Seto, T; Kanai, C; Suzuki, J; Yoshida, M; Uemura, N; Hamano, T. Analysis of azepane isomers of AM-2233 and AM-1220, and detection of an inhibitor of fatty acid amide hydrolase [3′-(aminocarbonyl)(1,1′-biphenyl)-3-yl]-cyclohexylcarbamate (URB597) obtained as designer drugs in the Tokyo area Forensic Toxicol., 10 Nov 2012, 31 (1), 76–85. 561 kB. https://doi.org/10.1007/s11419-012-0169-y #5 LC,MS,NMR,UV
Ujváry, I. The bumpy road ahead for forensic scientists. Synthetic cannabinoids to (unwel)come Spice II Plus, 5 Jun 2014. 405 kB. #URB-597
Banister, SD; Kumar, KK; Kumar, V; Kobilka, BK; Malhotra, SV. Selective modulation of the cannabinoid type 1 (CB1) receptor as an emerging platform for the treatment of neuropathic pain Med. Chem. Commun., 22 May 2019, 10 (5), 647–659. 810 kB. https://doi.org/10.1039/C8MD00595H #URB597
Yoshida, M; Suzuki, J; Nakajima, J; Nagashima, M; Takahashi, M; Uemura, N; Kanai, C; Moriyasu, T; Hamano, T; Nakae, D. Analysis of illegal drugs purchased in the fiscal year 2011 Ann. Rep. Tokyo Metr. Inst. P. H., 1 Jan 2012, 63 111–124. 575 kB. #URB597 MS,NMR,UV